The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

Lutetium PSMA is administered via a drip and travels through the bloodstream seeking out prostate cancer cells before hitting them with targeted internal radiation, the University Hospitals Sussex NHS ...

Prostate cancer often develops silently, leaving many unaware until it’s advanced.

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...

This may also help explain why coupled men statistically trend toward living ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

Prostate cancer diagnoses increased by 3% per year from 2014 to 2021, with the sharpest increase seen in advanced-stage disease. Prostate cancer mortality rates have continued to decline, but at a ...